< Back to search
Filter
1

Nutrition Intervention for Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC),
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 18+

Code: NCT07554560

Recruiting

PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma

for
PDAC - Pancreatic Ductal Adenocarcinoma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07047807

Recruiting

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC),
Location: Boston MA, Philadelphia PA, Fairfax VA, Tampa FL,
Sponsor: Kestrel Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07458347

Phase1, Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Boston MA, New York NY, Montreal, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07491445

Phase3, Recruiting

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

for
Locally Advanced Pancreatic Ductal Adenocarcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT07089940

Early_phase1, Recruiting

Interested in new adenocarcinoma, pancreatic ductal trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: New York NY, Philadelphia PA, Jacksonville FL,
Sponsor: BicycleTx Limited

Sex: All

Age: 18+

Code: NCT07450859

Phase2, Recruiting

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

for
Colorectal Cancer, Epithelial Ovarian Cancer, Gastric Cancer,
Location: Dallas TX
Sponsor: Blue Earth Diagnostics

Sex: All

Age: 18 - 70+

Code: NCT07432633

Phase1, Phase2, Recruiting

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

for
Metastatic Pancreatic Ductal Adenocarcinoma,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT07214298

Phase1, Phase2, Recruiting

A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer

for
Localized Pancreatic Ductal Adenocarcinoma,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07124611

Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

for
Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC),
Location: Baltimore MD, Fairfax VA, Toronto, San Antonio TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07223047

Phase1, Phase2, Recruiting

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

for
Pancreatic Ductal Adenocarcinoma,
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT06574620

Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07349537

Phase1, Recruiting

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Ductal Adenocarcinoma (mPDAC)
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT06790602

Phase2, Recruiting

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

for
Hepatocellular Carcinoma (HCC), Cholangiocarcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07224750

Recruiting

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: Boston MA, Worcester MA, New York NY, Philadelphia PA,
Sponsor: SOFIE

Sex: All

Age: 18+

Code: NCT07217717

Phase3, Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Sutro Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07227168

Phase1, Recruiting

Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07226154

Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: Boston MA, Hartford CT, New York NY, Philadelphia PA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase3, Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Chicoutimi, New York NY, Summit NJ, New Brunswick NJ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase2, Phase3, Recruiting

iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

for
KRAS NP_004976.2:p.G12D, Metastatic Pancreatic Adenocarcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03608631

Phase1, Phase2, Recruiting